IMST for Coronary Heart Disease
(BREATHE Trial)
Trial Summary
What is the purpose of this trial?
The goal of this single-site, parallel-group, double-blind, sham-controlled randomized control trial is to examine the effect of high-intensity inspiratory muscle strength training (IMST) on coronary blood flow assessed using positron emission tomography coronary perfusion imaging in patients with coronary artery disease (CAD). The main question it aims to answer are: • if high-intensity IMST will improve coronary blood flow in patients with CAD, which could be assessed using positron emission tomography coronary perfusion imaging. Participants will be asked to complete the 8-week high-intensity or low-intensity IMST. Researchers will compare high and low-intensity IMST groups to see if coronary blood flow increases after IMST.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications, but you must have had no changes in your medications for the past month to participate.
What data supports the effectiveness of the treatment for coronary heart disease?
Inspiratory muscle strength training (IMST) has been shown to improve respiratory muscle strength and quality of life in patients with heart failure and those undergoing coronary artery bypass grafting (CABG). This suggests that IMST could potentially benefit individuals with coronary heart disease by enhancing their respiratory function and overall well-being.12345
Is inspiratory muscle training (IMT) safe for humans?
How is the treatment IMST for coronary heart disease different from other treatments?
Inspiratory Muscle Strength Training (IMST) is unique because it focuses on strengthening the muscles used for breathing, which can improve respiratory strength and overall physical capacity. Unlike traditional treatments for coronary heart disease that may involve medication or surgery, IMST is a non-invasive exercise-based therapy that can be done at home using a handheld device.12349
Research Team
Benjamin Chow, MD
Principal Investigator
Ottawa Heart Institute Research Corporation
Eligibility Criteria
This trial is for adults over 18 who can do respiratory exercise tests and are stable, including no medication changes in the last month. They must be referred to PET at the University of Ottawa Heart Institute with coronary artery disease but without severe non-cardiac issues, unstable angina, severe valvular heart disease, hypertrophic cardiomyopathy or COPD.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete 8 weeks of high-intensity or low-intensity inspiratory muscle strength training (IMST)
Follow-up
Participants are monitored for changes in coronary blood flow and other health metrics after IMST
Treatment Details
Interventions
- High-intensity IMST
- Low-intensity IMST
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor